Read our bumper June 2018 issue

Introducing our June issue, we include a range of company profiles and feature articles focused on infectious diseases, IP protection and fibrosis.

Like 0 Comment

Our biggest issue of the year is here. Features and company profiles included cover infectious diseases, life science IP protection and fibrosis.

Features include - 

  • Exploring the infectious disease landscape
  • How to protect your intellectual life science IP
  • Focus on fibrosis

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.